A note before the argument: MedFlow is a vendor. What follows is a case that a practice should buy fewer tools, made by a company that would like to be one of them. Read it with that in mind. The reason we are writing it anyway is that the pattern below is the single most common thing we hear on calls, and it is usually described by the person who has to live inside it.
A practice lead we work with put it plainly. In her ideal world she would find two or three vendors who could handle eighty percent of what her current stack does, because managing all of these tools is adding more work and complexity than they are worth.
Each tool automates a part and returns the rest
A point solution is bought to fix one step. It usually does fix that step. What it rarely does is finish the workflow the step belonged to, because the rest of that workflow lives in systems the vendor does not reach.
So the automation stops partway and hands the remainder back. Someone exports a list. Someone re-keys a result into the chart. Someone checks whether the thing the tool said it did actually happened. Each of these takes a couple of minutes and none of them appears in any evaluation of the tool, because the tool did what it promised. The gap it left is charged to the staff instead.
The switching cost is the part nobody prices
Buying a tool has a price. Learning it does not, and neither does moving between it and the six others open in the same shift.
Every tool has its own login, its own idea of what a patient record looks like, and its own place where work is considered done. A member of staff carrying eight of those is not doing eight jobs, they are doing one job across eight surfaces and holding the seams together in their head. That holding is invisible until someone is on leave and the seams come apart.
Thin integration turns into permanent workarounds
When a tool integrates shallowly with the EHR, the practice does not stop using it. The practice invents a workaround, and the workaround becomes procedure.
The workarounds are individually reasonable and collectively expensive, because each one is a rule that exists nowhere except in the habits of the people who built it. Ask why a step happens and the answer is often that a tool needed it three years ago. Add a ninth vendor and you have not added a ninth workflow, you have added a ninth set of seams to every workflow already there.
Why the market keeps producing this
It is tempting to read the result as vendors being careless. The more useful reading is that it is what the incentives produce.
A vendor that goes deep on one specialty in one EHR has a smaller market than one that goes shallow across all of them. Depth means understanding a workflow well enough to finish it, which means configuration, which means support, which means people. Breadth costs less to sell and less to run. So the pressure runs toward covering many systems thinly, customizing as little as possible, and supporting as little as possible.
None of that is hidden. It is visible in what a practice can observe from the outside: capability that stops at the edge of a demo, configuration that is not really offered, and support that answers slowly because there is not much of it. A practice buying its ninth tool is not being fooled. It is buying the only shape the market makes in volume.
What fewer, deeper looks like
The alternative is not one vendor for everything. That is the same mistake wearing a different hat, and no single company is good at more than a few things.
It is that a tool should own a workflow end to end rather than a step in the middle of one. If it finds the patient, it should place the action and record what happened, inside the system the practice already runs on, so there is no export, no re-keying, and no second place to check.
There is a fair test for any vendor, us included. Ask what the staff still has to do by hand after the tool has run. If the answer is a list, the tool has automated a step and left you the workflow.
One more thing the notes said
The same conversation ended somewhere we did not expect. Asked what she would fix first, the practice lead did not say chart preparation. She said getting patients through the door: the no-shows, the missed appointments, the people still on the roster who have not been seen in two years and do not answer the phone.
That is worth repeating without softening it, because it is a correction to how this category usually talks about itself, ours included. The work before the visit is not the expensive part. The patient who never arrives is.